PUL-Mediated Plant Cell Wall Polysaccharide Utilization in the Gut Bacteroidetes

Plant cell wall polysaccharides (PCWP) are abundantly present in the food of humans and feed of livestock. Mammalians by themselves cannot degrade PCWP but rather depend on microbes resident in the gut intestine for deconstruction. The dominant Bacteroidetes in the gut microbial community are such bacteria with PCWP-degrading ability. The polysaccharide utilization systems (PUL) responsible for PCWP degradation and utilization are a prominent feature of Bacteroidetes. In recent years, there have been tremendous efforts in elucidating how PULs assist Bacteroidetes to assimilate carbon and acquire energy from PCWP. Here, we will review the PUL-mediated plant cell wall polysaccharides utilization in the gut Bacteroidetes focusing on cellulose, xylan, mannan, and pectin utilization and discuss how the mechanisms can be exploited to modulate the gut microbiota.     

Pectic Galactan Polysaccharide-Based Gene Delivery System for Targeting Neuroinflammation

Treating neuroinflammation-related injuries and disorders through manipulation of neuroinflammation functions is being heralded as a new therapeutic strategy. In this study, a novel pectic galactan (PG) polysaccharide based gene therapy approach is developed for targeting reactive gliosis in neuroinflammation. Galectin-3 (Gal-3) is a cell protein with a high affinity to β-galactoside sugars and is highly expressed in reactive gliosis. Since PG carries galactans, it can target reactive gliosis via specific carbohydrate interaction between galactan and Gal-3 on the cell membrane, and therefore can be utilized as a carrier for delivering genes to these cells. The carrier is synthesized by modifying quaternary ammonium groups on the PG. The resulting quaternized PG (QPG) is found to form complexes with plasmid DNA with a mean diameter of 100 nm and have the characteristics required for targeted gene therapy. The complexes efficiently condense large amounts of plasmid per particle and successfully bind to Gal-3. The in vivo study shows that the complexes are biocompatible and safe for administration and can selectively transfect reactive glial cells of an induced cortical lesion. The results confirm that this PG-based delivery system is a promising platform for targeting Gal-3 overexpressing neuroinflammation cells for treating neuroinflammation-related injuries and neurodegenerative diseases.     

金针菇多糖对微冻大黄鱼及其鱼片品质变化的影响

为研究金针菇多糖（polysaccharide from Flammulina velutipes，FVP）对微冻大黄鱼及鱼片在贮藏期间肌原纤维蛋白性质的变化及水分分布的影响，实验分别选用0.03、0.06、0.09 g/L FVP浸渍处理大黄鱼和鱼片，以无菌水处理为对照组，分析微冻贮藏期间样品的感官指标得分、总挥发性盐基氮含量、总巯基含量、Ca2＋-ATPase活性、蛋白流变学性质以及水分迁移变化规律。结果表明：FVP可有效抑制整鱼总挥发性盐基氮含量上升和感官得分的下降；减缓整鱼及鱼片在微冻过程中总巯基含量、Ca2＋-ATPase活性下降和水分流失；此外FVP还能够延缓大黄鱼因腐败而出现的蛋白凝胶能力减弱。在本实验选取的多糖浓度范围内，0.09 g/L FVP处理组保鲜效果较强。该研究结果可为FVP用于水产品贮运保鲜提供理论参考。     

Extraction and characterisation of pectin polysaccharide from soybean dreg and its dispersion stability in acidified milk drink

In this study, pectin polysaccharide (SDPP) was obtained from soybean dreg (26.2% yield), and characteristics of SDPP were compared with those of soybean soluble polysaccharides (SSPS) and citrus pectin (HMP). The galacturonic acid and molecular weight of SSPS, SDPP or HMP were 11.8%, 40.6% or 70.2% and 112, 446, or 440 kDa. SDPP had similar viscosity and protein content to SSPS, and functional groups and linear structure to HMP. SSPS, SDPP or HMP differed in particle size of 260, 467 or 1195 nm and ζ–potential of −5.8, −14.6 or −23.5 mV at pH 4.0. The precipitation of acidified milk drink (AMD) was 6.31% without stabiliser or below 1.75% with 0.4% SDPP at pH 3.6–4.6. These results suggested that SDPP combines the structure and characteristic of HMP and SSPS, and AMD with SDPP had great stabilising behaviour at wider pH range (pH 3.6–4.6).     

芜菁子挥发油、多糖的组成及挥发油抗菌活性的研究

目的用3种方法提取芜菁子挥发油,对挥发油的抗菌作用进行定性和定量分析,并对芜菁子挥发油及多糖的组成进行分析。方法采用水蒸气蒸馏法、溶剂萃取法和同时蒸馏萃取法提取芜菁子挥发油,气相色谱-质谱联用法分析挥发油的组成。运用滤纸片扩散法和二倍稀释法检验芜菁子挥发油对大肠杆菌、金黄色葡萄球菌和绿脓杆菌的抑菌作用。利用水提醇沉法提取残渣中的多糖,酸水解后进行薄层分析。结果 3种方法提取的挥发油分别鉴别出21、7、14种成分。水蒸气蒸馏法提取挥发油中异硫氰酸酯类化合物占45.95%,同时蒸馏萃取法的为31.35%,溶剂萃取法提取挥发油无异硫氰酸酯类化合物。定性定量的抑菌实验结果显示,3种方法所得的挥发油对大肠杆菌、金黄色葡萄球菌和绿脓杆菌均有良好的抑制作用,水蒸气蒸馏法提取的挥发油的抑菌效果最好。在高效G板上,以乙酸乙酯:异丙醇:水=26:14:7(V:V:V)为展开剂,芜菁子多糖的分离效果较好,可鉴别出芜菁子多糖中的果糖和半乳糖。结论芜菁子挥发油对大肠杆菌、金黄色葡萄球菌、绿脓杆菌均有一定的抑制作用,可能与其中含有异硫氰酸酯类和腈类化合物有关。     

4株羊肚菌胞外多糖含量及其生物活性的研究

为探讨不同羊肚菌菌株胞外多糖的含量及其抑菌、抗氧化活性和对α-淀粉酶的抑制作用是否有差异,以4株羊肚菌(编号为YS-Y、XH-0、XH-2、XH-4)为材料,利用醇沉法提取羊肚菌胞外多糖,并用Sevag法去除蛋白后,测定其胞外多糖含量及其抑菌活性、抗氧化能力和对α-淀粉酶的抑制作用,并将其结果进行对比。结果表明,YS-Y、XH-0、XH-2、XH-44株羊肚菌胞外多糖的含量分别为10.05%、5.80%、19.89%、8.34%;4株羊肚菌具有一定程度的抑菌能力,菌株XH-2的抑菌效果优于其它3株,且对金黄色葡萄球菌和大肠杆菌的抑制效果最好;4株羊肚菌的还原力、DPPH自由基、ABTS+自由基以及羟自由基清除率都随着质量浓度的增大而增大,当质量浓度达到1.0 mg/mL时,菌株XH-2的还原能力和ABTS+自由基清除能力优于其他3株,其OD700值和EC50分别为0.136和0.56 mg/mL;菌株XH-4的DPPH和羟自由基清除率优于其它3株,其EC50分别为16.68 mg/mL和1.40 mg/mL,且4株羊肚菌的羟自由基清除率均大于VC;菌株XH-2对α-淀粉酶的抑制作用优于其它3株,其EC50为1.55mg/mL。该研究表明羊肚菌胞外多糖具有一定的生物活性,菌株XH-2和XH-4具有更大的药用潜力,可为羊肚菌资源开发提供一定的参考意义。     

GC和HPLC分析金银花多糖的单糖组成方法比较

目的:GC法和HPLC法分析金银花多糖的单糖组成,并对两种方法进行比较。方法:金银花多糖经2.0 mol·L-1的三氟乙酸水解后,用糖腈乙酸酯衍生化-GC法和1-苯基-3-甲基-5-吡唑啉酮(PMP)柱前衍生化-HPLC法分别测定其单糖组成及其比例。结果:GC法检测出金银花多糖由鼠李糖(L-Rha)、阿拉伯糖(D-Ara)、甘露糖(D-Man)、木糖(D-Xyl)、葡萄糖(D-Glc)、半乳糖(D-Gal)组成;HPLC法检测到金银花多糖中含有甘露糖(D-Man)、鼠李糖(L-Rha)、葡萄糖醛酸(D-GlcA)、葡萄糖(D-Glc)、半乳糖(D-Gal)、阿拉伯糖(D-Ara)和木糖(D-Xyl),其中半乳糖(D-Gal)与阿拉伯糖(D-Ara)的色谱峰重叠。结论:两种方法均能检测出中性糖,HPLC法不仅能测中性糖,还能检测出葡萄糖醛酸,对金银花多糖的单糖组成分析GC与HPLC联合使用较为合适。     

桦褐孔菌纯化多糖体外降血糖活性研究

采用水提醇沉法得到桦褐孔菌发酵粗多糖,将粗多糖过DEAE-52纤维素柱分离纯化得到两种多糖(EIOP1、EIOP2),本文以α-葡萄糖苷酶抑制活性、正常HepG2细胞及胰岛素抵抗HepG2细胞的单位细胞葡萄糖消耗量为主要指标,探究桦褐孔菌两种纯化多糖不同浓度(10、20、40、80、160和320 μg/mL)的降血糖活性,其中α-葡萄糖苷酶抑制活性以阿卡波糖作为阳性对照,葡萄糖消耗实验以二甲双胍作为阳性对照。结果表明,EIOP1、EIOP2的α-葡萄糖苷酶抑制活性均高于阳性对照组阿卡波糖与粗多糖,IC₅₀值分别为39.18、29.87 μg/mL。EIOP1在浓度为80 μg/mL时,对HepG2细胞的葡萄糖消耗量极显著高于对照组,促进效果最好,比对照组提高了30.62%(P<0.01);EIOP2在浓度在40 μg/mL时,葡萄糖消耗量极显著高于对照组,比对照提高了75.99%(P<0.01);对胰岛素抵抗HepG2细胞的葡萄糖消耗实验发现EIOP1在浓度为40 μg/mL时,促进效果最好,比胰岛素抵抗组提高了30.00%,EIOP2在浓度为80 μg/mL时,促进效果最好,比胰岛素抵抗组提高了90.49%,高于Met组(P<0.01)。因此,桦褐孔菌纯化多糖对正常HepG2细胞和胰岛素抵抗HepG2细胞的葡萄糖消耗均具有促进作用,对α-葡萄糖苷酶的抑制活性显著高于粗多糖。